603108 润达医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入5,268,460-14.70%8,311,7809,147,37310,494,4198,860,108
减:营业总成本5,307,472-10.37%7,994,7838,651,9939,643,2848,160,246
    其中:营业成本4,134,821-9.97%6,203,4926,718,3717,557,0676,468,094
               财务费用203,149-14.15%313,435316,682323,591291,634
               资产减值损失(70)-98.09%(36,170)(34,500)(40,772)(7,299)
公允价值变动收益------------
投资收益66,887-31.62%109,821231,999137,048137,876
    其中:对联营企业和合营企业的投资收益65,939-31.84%108,488139,609138,057133,628
营业利润(57,510)-122.25%354,060646,803816,373777,798
利润总额(61,788)-123.67%345,542655,555819,651780,456
减:所得税费用64,416-45.82%156,084212,920164,541182,255
净利润(126,204)-188.81%189,458442,636655,110598,201
减:非控股权益36,488-60.20%134,177169,339237,364217,972
股东净利润(162,692)-422.64%55,281273,296417,746380,229

市场价值指针
每股收益 (元) *-0.270-437.50%0.0900.4700.7200.660
每股派息 (元) *----0.0300.1000.150--
每股净资产 (元) *6.838-3.23%7.1367.0606.5195.785
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容